Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - LONG-TERM DEBT
Long-term Debt RARE - Ultragenyx Pharmaceutical Inc.
30.6 M
LAST VALUE
-71.73%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR